BioCentury
ARTICLE | Company News

Morphochem, Sosei to optimize anti-cancer lead

March 14, 2001 8:00 AM UTC

Morphochem (Munich, Germany) will use its multi-component reaction chemistry technology to produce diverse libraries of natural-like small molecules similar to Sosei's lead telomerase inhibitor compou...